According to the definition given in the Biomedical Research Act 14/2007, a biobank is “a public or private non-profit-making establishment which has a collection of biological samples intended for diagnostic purposes or biomedical research and organised as a technical unit with criteria involving quality, order and allocation”.

CIBERER BIOBANK, hereinafter CBK, is a public-non-profit-making biobank set up by the Centre for Biomedical Network Research on Rare Diseases (CIBERER) and located at the Centro Superior de Investigación en Salud Pública (CSISP) in Valencia. Through being an integral part of the CIBERER, the Biobank has the institutional backing of the Instituto de Salud Carlos III.

The CBK was founded with clear aspirations to excellence and differentiation. It has set out to become a biobank centralising the reception of samples connected with rare diseases in Spain. It also actively involves the research or healthcare professionals who send the samples and disseminates these among national and international research groups in rare diseases. It thus guarantees the scientific repercussion of the samples received.